• medical physics summary talk...35:08 shkodra 6/10/2014 - y. lemoigne / ifmp – ambilly –...
TRANSCRIPT
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
• MEDICAL PHYSICS SUMMARY TALK
Y. Lemoigne
P. Altieri
K. Theodorou
C. Cachard
H. Liebgott
D. Miladinova
S. Petkovska
MEDICAL PHYSICS in SHKODRAMEDICAL PHYSICS in SHKODRAMEDICAL PHYSICS in SHKODRAMEDICAL PHYSICS in SHKODRADefinitively Oriented !
What did we learned of What did we learned of What did we learned of What did we learned of Important (Important (Important (Important (…………my opinion!)my opinion!)my opinion!)my opinion!)
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
Yves LEMOIGNE,Yves LEMOIGNE,Yves LEMOIGNE,Yves LEMOIGNE, PhD IFMP, PhD IFMP, PhD IFMP, PhD IFMP, TERA & CERN, GenevaTERA & CERN, GenevaTERA & CERN, GenevaTERA & CERN, Geneva
1. Ultrasound (C. Cachard, H. Liebgott)
2. CT-scanner (with X-Rays)
3. SPECT
4. PET, PET-CT
5. MRI (Cf. Kyriaki Theodorou)
7. Med. Imaging in Hospital (D. Miladinova, S. Petkosvska)
8. Innovative Therapy with Ultrasound (H. Liebgott)
9. Innovation in Radiotherapy (P. Altieri, K. Theodorou)
MEDICAL PHYSICS was mainly,
MEDICAL IMAGING
with also innovative Therapy (US, Hadrons)
PETCT
Short review of Medical Imaging techniques
Innovative Therapy
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
1. ULTRASOUND
Christian Cachard & Hervé Liebgott
Lyon, France
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
Real time imaging
• 10 to 60 frames/s
IN L
IVE
ULTRASOUND (C.Cachard)ULTRASOUND (C.Cachard)ULTRASOUND (C.Cachard)ULTRASOUND (C.Cachard)
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
ULTRASOUND (C.Cachard)
Longitudinal motion of the carotid artery
wall as a new marker of cardiovascular risk
1
2
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
Longitudinal motion of the carotid artery wall as a
new marker of cardiovascular risk
(cont’d video)
3
4
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
Doppler systems building blocks: Doppler systems building blocks: Doppler systems building blocks: Doppler systems building blocks: Doppler systems building blocks: Doppler systems building blocks: Doppler systems building blocks: Doppler systems building blocks:
Pulsed wave (PW) systemsPulsed wave (PW) systemsPulsed wave (PW) systemsPulsed wave (PW) systemsPulsed wave (PW) systemsPulsed wave (PW) systemsPulsed wave (PW) systemsPulsed wave (PW) systems
Transmitter
Flow
·A single transduceracts as transmitter and receiver
Bursts of US energy are transmitted into the body at rate PRF
GateReceiver
Processing
Display
Audiooutput
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
C. Cachard : EchoC. Cachard : EchoC. Cachard : EchoC. Cachard : EchoC. Cachard : EchoC. Cachard : EchoC. Cachard : EchoC. Cachard : Echo--------Doppler (Duplex) Doppler (Duplex) Doppler (Duplex) Doppler (Duplex) Doppler (Duplex) Doppler (Duplex) Doppler (Duplex) Doppler (Duplex)
examplesexamplesexamplesexamplesexamplesexamplesexamplesexamples
Healthy Common Carotid Artery Stenotic Internal Carotid Artery
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
10
Example 3D: fetus (movie)
Hervé Liebgott : 3 D Imaging
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
*
Hervé Liebgott : 3 D Imaging
<=Transesophageal imaging
Transthoracic imaging =>
Courtesy of Lasse Lovstakken (NTNU Trondheim)
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
12http://keckmedicine.adam.com/
H. Liebgott: Example: insertion of a
catheter for the studies of the coronary
arteries
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
13
Example: insertion of a catheter
for the studies of the coronary
arteries
Hervé Liebgott:
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
14
Stent in water(CREATIS) illustration of geometrical artefacts
Stent in a vessel with stenosis (www.vasculardiseasemanagement.com)
Hervé Liebgott:
media4.mp4
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
15
1) Complex motion visualization: blood flow1) Complex motion visualization: blood flow1) Complex motion visualization: blood flow1) Complex motion visualization: blood flow
Ultrafast
vector flow in the carotid
bifurcation of
a healthy subject
Courtesy of Alfred Yu, Hong Kong University
Hervé Liebgott:
Here reversed or turning flow
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
16
1) Complex motion visualization: blood flow
Ultrafast vector flow in the carotid bifurcation of a subject with 50% eccentric stenosis
Courtesy of Alfred Yu, Hong Kong University
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
• Perimembranous ventricular septal defect (significant shunt)
• 36 days old, 4259 gr.
VectorVector--flow imagingflow imagingColorColor--Doppler + vectorDoppler + vector--flowflowColorColor--DopplerDopplerBB--modemode
Image source: Wikipedia, Pat Lynch
LV
LA
RV
1) Complex motion
visualization:
cardiac flow
Courtesy of Lasse Lovstakken, NTNU Trondheim, Norway
Hervé Liebgott:
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
• Perimembranous ventricular septal defect (significant shunt)
• 36 days old, 4259 gr.
VectorVector--flow imagingflow imagingColorColor--Doppler + vectorDoppler + vector--flowflowColorColor--DopplerDopplerBB--modemode
Image source: Wikipedia, Pat Lynch
LV
LA
RV
Complex motion visualization: cardiac flow
Courtesy of Lasse Lovstakken, NTNU Trondheim, Norway
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
Photo-acoustic imaging
Optical
imaging
Ultrasound
imaging
Contrast
Resolution > ~ 1 mm
Investigation depth < ~ 5 cm
Functional information
Contrast
Resolution > ~ 100 µm
Investigation depth ~ 10 cm
No Functional information
Contrast (optical abosption)
Resolution of Ultrasound
Depth of investigation
Functional information due to optical absorption
Non invasive, non inonizing
WHY Photo-acoustic imaging?
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
H. LiebgottH. LiebgottH. LiebgottH. Liebgott: Physical principle: Physical principle: Physical principle: Physical principle
Ultrasound generation with lightUltrasound generation with light
Laser pulseLaser pulseLocal
absorption by
tissues
Local
absorption by
tissues
Thermal
expansion
Thermal
expansionAcoustic
wave
Acoustic
wave
LASER
Optical
absorber
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
Vascularization
Cancer � abnormal vascularization
In vivo PA image of the hand
vascularization. UCL PA Imaging
Group
H. Liebgott:H. Liebgott:H. Liebgott:H. Liebgott: ApplicationsApplicationsApplicationsApplications
3D photoacoustic imaging of
melanoma in vivo. Zhang
et.al. Nature Biotechnology
2006
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
OTHER DEVICESOTHER DEVICESOTHER DEVICESOTHER DEVICES
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
From Craig S Levin. Eur J Nucl Med & Mol Imag. 2005, 32(14), S-325-45
Add the best capabilities of two cameras
Spatial resolution (CT)+ Sensitivity (PET)
Imaging
Modality
Spatial
Resolution (mm)
Acquisition
time per
frame(s)
Molecular
probe mass
required (ng)
Molecular
sensitivity
(mol/L)
Tissue
penetration
depth (mm)
Signal
quantification
capabilities
US 0.05-0.5 (animal)
0.1-1 (clinical)
0.1-100 103-106 Not well characterized
1-300 Low
CT 0.03-0.4 (animal)
0.5-1 (clinical)
1-300 NA Not well
characterized>300 Medium-
High
SPECT 0.5-2 (animal)
7-15 (clinical)60-2000 1-100 10-10-10-11 >300 Medium-
High
PET 1-2 (animal)
6-10 (clinical)1-300 1-100 10-11-10-12 >300 High
PET-CT 0.03-0.4 (animal)
0.5-1 (clinical))
1-300 1-100 10-11-10-12 >300 High
MRI 0.025-0.1 (animal)
0.2 (clinical)0.1-100 103-106 10-3-10-5 >300 High
23(PET-CT from myself)
Next: PET-MRI ?
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
Restaging gastric cancer
Scan duration: 15 min
5 beds; 3 min/bed; 8s/3i/6F
10.6 mCi; 90 min post-injection
A 52 year-old male patient with history of gastric cancer imaged pre- and post-therapy (after ½ year)
Scan duration: 15 min
5 beds; 3 min/bed; 8s/3i/6F
9.8 mCi; 90 min post-injection
Pre-therapy
Post-therapy
Pre-therapy (4/06) Post-therapy (10/06)With Biograph
½½½½ year Post / Pre treatment Surveyyear Post / Pre treatment Surveyyear Post / Pre treatment Surveyyear Post / Pre treatment Survey
6 monthslater
* *
Example in help for PostExample in help for PostExample in help for PostExample in help for Post----treatment surveytreatment surveytreatment surveytreatment survey
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
SURVEY : Vaginal cancer
A 50 year-old female patient restaged for vulvar cancer with history of NHL (Non-
Hodgkin lymphoma),. The PET/CT scan shows focal uptake in right aspect of the vulva (SUV: 10.3). Adjacent focal anorectal uptake (SUV: 5.5). CT is negative with no abnormality seen. Only combination of CT and PET can show that!
Biograph Scan duration: 15 min
5 beds; 3 min/bed; 8s/3i/6F
10.6 mCi; 90 min post-injection
CT only
PET+CT
PET only
PETPETPETPET----CT is more powerful than PET aloneCT is more powerful than PET aloneCT is more powerful than PET aloneCT is more powerful than PET alone…………....
*
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
EVOLUTION in MEDICAL IMAGINGEVOLUTION in MEDICAL IMAGINGEVOLUTION in MEDICAL IMAGINGEVOLUTION in MEDICAL IMAGING(combination of existing equipment)(combination of existing equipment)(combination of existing equipment)(combination of existing equipment)
ToToToTo
REVOLUTIONREVOLUTIONREVOLUTIONREVOLUTION in MEDICAL IMAGING in MEDICAL IMAGING in MEDICAL IMAGING in MEDICAL IMAGING @Hospital @Hospital @Hospital @Hospital !!!!
(Integrated devices only possible from (Integrated devices only possible from (Integrated devices only possible from (Integrated devices only possible from recent technical developments)recent technical developments)recent technical developments)recent technical developments)
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
Combined whole-body PET/CT to PET/MR..
PET/CT
PETPETPETPET CTCTCTCT
PET
MDCT
PET
PET/MR
PET MR
(S.R. Cherry,
Magnet
Magnet
PET
PET
MRMRMRMRPETPETPETPET
=> Patient is moved
=> No patient movement
High Field Magnet
High Field Magnet
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
EVOLUTION in MEDICAL IMAGING(combination of existing equipment)
Data taken at different time / in different configuration / in different places…
Fusion only by software
Data taken at sequential time / with minimal movement of patient
Fusion by software
CT PETExample:
movement
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
(same hardware)
REVOLUTION in MEDICAL IMAGING !(Integrated devices from technical developments)
Example: MRT PET
No movement !
REVOLUTION is simultaneous Acquisitions without patient deplacement !!
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
MAGNETIC RESONANCE IMAGING
Cf. Talk of Kyriaki TheodorouInside the exceptional performance of this method:
- Excellent spatial resolution (ok for anatomy)
- No Radiation (only Noise unfortunatly…)
- Any type of contrast availlable
- Functional imaging : Two exemples:• Diffusion Weighted Imaging (DWI), Diffusion Diffusion Weighted Imaging (DWI), Diffusion Diffusion Weighted Imaging (DWI), Diffusion Diffusion Weighted Imaging (DWI), Diffusion Tensor Imaging (DTI)Tensor Imaging (DTI)Tensor Imaging (DTI)Tensor Imaging (DTI)=> Fiber Tracking=> Fiber Tracking=> Fiber Tracking=> Fiber Tracking
• Spectroscopy capability:Spectroscopy capability:Spectroscopy capability:Spectroscopy capability:With MRS, MR has impressive results to ANALYSE IN-VIVO what molecules are present inside the body (Only MR can do that so well…)=> Powerful tool for diagnostic
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
6/10/2014 Kiki Theodorou 31
MRI – Advanced Techniques
Diffusion Weighted Imaging (DWI)
The measurement of the degree of diffusion anisotropy can yield useful biological information on the tissue’s microstructure, e.g. degree of myelination.
An ordered structure has
predominantly a left–right orientation.
These inferences are entirely consistent
with the fibers of the corpus callosum,
which passes through this region.
�ADC is rotational variable
�A single ADC is inadequate for characterizing diffusion
Apparent Diffusion
Coefficient (ADC)
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
6/10/2014 Kiki Theodorou 32
MRI – Advanced Techniques
Diffusion Tensor Imaging (DTI)
Xue R., et.al., Magn. Reson. Med. 42 (1999), 1123–1127
=> Fiber Tracking
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
6/10/2014 Kiki Theodorou 33
ANALYSE IN-VIVO what molecules are presentinside the body (Only MR can do that so well…)
=> Powerful tool for diagnostic (cf. LL, or 3.8 peaks.)
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
For about 10% of severe cases which cannot For about 10% of severe cases which cannot For about 10% of severe cases which cannot For about 10% of severe cases which cannot
be treated by gamma Photons:be treated by gamma Photons:be treated by gamma Photons:be treated by gamma Photons:
• Radioresistive cellsRadioresistive cellsRadioresistive cellsRadioresistive cells
• Pediatric cancerPediatric cancerPediatric cancerPediatric cancer
• Very difficult configuration of tumor Very difficult configuration of tumor Very difficult configuration of tumor Very difficult configuration of tumor
Example: Proximity of Cave vein in leaverExample: Proximity of Cave vein in leaverExample: Proximity of Cave vein in leaverExample: Proximity of Cave vein in leaver
INNOVATIVE RADIOTHERAPY =INNOVATIVE RADIOTHERAPY =INNOVATIVE RADIOTHERAPY =INNOVATIVE RADIOTHERAPY =
HADRONTHERAPYHADRONTHERAPYHADRONTHERAPYHADRONTHERAPY
Talks from : Palma Altieri, Kiki Theodorou
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
35
P. Altieri: PHYSICAL BASICS Hadron TherapyHadron TherapyHadron TherapyHadron Therapy
Treatment of tumors through external irradiation by means of
accelerated hadronic particles:
neutrons, protons, pions, antiprotons, helium, lithium, boron,
carbon and oxygen ions. Protons and heavy ions (particles with mass greater than helium)
have physical properties, and so radiobiological effects, such that:
1.high and conformal dose is delivered to the tumor target;
2.minimazing the irradiation of healthy tissue.
HadronsPhotons
Ionization density Effect on cellular DNA
Double strands that make up the DNA helix
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
P. Altieri:BIOLOGICAL BASICS
36
DX-rays
Dparticle
RBE =
Relative Biological Effectiveness (RBE)
RBE depens on many factors:
• energy;
• particle type;
• organ dimensions;
• tissue type;
• presence of oxygen.
hadrons more biologically effective than
photons: lower dose is required to cause the
same biological effect
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
37
Physical advantages :
� finite range and high
ionization density;
� lower integral dose;
� small lateral scattering
(larger flexibility).
TC image: dose distribution calculated for
proton beams and X-rays.
Protons vs photons P. Altieri: BIOLOGICAL BASICS
Clinical advantages :
� treatment of deep-seated, irregular
shaped and radioresistant tumors;
� small probability of side effects in
normal tissue (critical structrure);
� proton therapy suitable for
pediatric diseases (reduced toxicity).
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
Greek Hadrontherapy project
Kiki TheodorouKiki TheodorouKiki TheodorouKiki Theodorou
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
6/10/2014 Kiki Theodorou 39
Cancer Facts – Epidemiological Data in EU
Efficiency of detection
95%
80%
70%
30%
Or less ?
YL comment : These figures have to be weighted by efficiency of detection by each National Health Service:
it is only my guess
to be verified. (YL)
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
6/10/2014 Kiki Theodorou 40
Hadron Facility in Greece - Feasibility
Existing Infrastructure
� 1.5 M people immediate health coverage
� 3ry care University Hospital
� Medical School
� Institute for Research & Technology
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
6/10/2014 Kiki Theodorou 41
CERN
Medical
School
I.R.E.TH
NTUA
Industry
Funding
agencies
Biologists
Engineers
DoctorsPolicy
makers
Physicists
& Medical
physicists
Epidemiologists
Need Multidisciplinary / Collaboration
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
MEDICAL PHYSICS IN MEDICAL EDUCATION AND
HOSPITAL SETTINGS
Daniela Miladinova, MD PhD
Nikola Jankulovski, MD PhD
Faculty of Medicine, University Ss Cyril and Methodius
International Conference on LHC, Astrophysicis, Medical and Environmental Physics
Shkoder, 8th October 2014
Med Phys @ University & HospitalMed Phys @ University & HospitalMed Phys @ University & HospitalMed Phys @ University & Hospital
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
Nowadays, UKIM through figures is: around Nowadays, UKIM through figures is: around 60.000 enrolled students 60.000 enrolled students from Republic of from Republic of Macedonia in first and second cycle of studies, as well as over Macedonia in first and second cycle of studies, as well as over 700 foreign students700 foreign students. The . The third cycle doctoral studies is realized within the School of third cycle doctoral studies is realized within the School of doctoral studies with more doctoral studies with more than 600 studentsthan 600 students..
More than 3100 teaching, research, associate as well as administMore than 3100 teaching, research, associate as well as administrative staffrative staff
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
FACULTY OF MEDICINEFACULTY OF MEDICINEFACULTY OF MEDICINEFACULTY OF MEDICINEFACULTY OF MEDICINEFACULTY OF MEDICINEFACULTY OF MEDICINEFACULTY OF MEDICINE
ORGANIZATIONAL STRUCTUREORGANIZATIONAL STRUCTUREORGANIZATIONAL STRUCTUREORGANIZATIONAL STRUCTUREORGANIZATIONAL STRUCTUREORGANIZATIONAL STRUCTUREORGANIZATIONAL STRUCTUREORGANIZATIONAL STRUCTURE
•• 34 Departments/Cathedras34 Departments/Cathedras
•• 12 Institutes12 Institutes--full time full time employeedemployeed at the Faculty of at the Faculty of MedicineMedicine
•• 24 University Clinics 24 University Clinics –– part time part time employeedemployeed at the at the Faculty of Medicine Faculty of Medicine
•• 10 Affiliated Educational Institutions (10 Affiliated Educational Institutions (--Institute of Institute of public health)public health)
•• 2 Centers (Center for public health and Center for 2 Centers (Center for public health and Center for family medicine) family medicine)
Daniela Miladinova, MD PhD
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
FACULTY OF MEDICINEFACULTY OF MEDICINEFACULTY OF MEDICINEFACULTY OF MEDICINEFIRST YEAR OF STUDIESFIRST YEAR OF STUDIESFIRST YEAR OF STUDIESFIRST YEAR OF STUDIES
• Anatomy 1 & 2
• Biophysics
• Hospital care
• Medical chemistry
• Medical psychology
• Histology and
embriology 1 & 2
• Introduction to
medicine and medical
professions
• Social medicine
• Cell morphology and
physiology
• Medical ethics
• Basics in human
genetics
• First aidDaniela Miladinova, MD PhD
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
-NUCLEAR MEDICINE (mandatory in 3rd y. with 1.5ECTS)
-RADIOLOGY RADIOLOGY RADIOLOGY RADIOLOGY
(mandatory in 3rd y. with 3.5 ECTS)(mandatory in 3rd y. with 3.5 ECTS)(mandatory in 3rd y. with 3.5 ECTS)(mandatory in 3rd y. with 3.5 ECTS)---- RADIOTHERAPY AND ONCOLOGYRADIOTHERAPY AND ONCOLOGYRADIOTHERAPY AND ONCOLOGYRADIOTHERAPY AND ONCOLOGY---- GRADUATE MEDICAL NURSE/TECHNICIANGRADUATE MEDICAL NURSE/TECHNICIANGRADUATE MEDICAL NURSE/TECHNICIANGRADUATE MEDICAL NURSE/TECHNICIAN---- SPEECH AND LANGUAGE THERAPISTS SPEECH AND LANGUAGE THERAPISTS SPEECH AND LANGUAGE THERAPISTS SPEECH AND LANGUAGE THERAPISTS ---- PHYSIOTHERAPISTS PHYSIOTHERAPISTS PHYSIOTHERAPISTS PHYSIOTHERAPISTS ---- RADIOLOGICAL TECHNOLOGISTS RADIOLOGICAL TECHNOLOGISTS RADIOLOGICAL TECHNOLOGISTS RADIOLOGICAL TECHNOLOGISTS -------- POSTGRADUATE STUDIES (in medical nuclear POSTGRADUATE STUDIES (in medical nuclear POSTGRADUATE STUDIES (in medical nuclear POSTGRADUATE STUDIES (in medical nuclear physics) physics) physics) physics) ---- APPLICATIVE PHYSICS IN CLINICAL PRACTICE (in APPLICATIVE PHYSICS IN CLINICAL PRACTICE (in APPLICATIVE PHYSICS IN CLINICAL PRACTICE (in APPLICATIVE PHYSICS IN CLINICAL PRACTICE (in nuclear medicine) nuclear medicine) nuclear medicine) nuclear medicine) ---- APPLICATIVE PHYSICS IN CLINICAL PRACTICE (in APPLICATIVE PHYSICS IN CLINICAL PRACTICE (in APPLICATIVE PHYSICS IN CLINICAL PRACTICE (in APPLICATIVE PHYSICS IN CLINICAL PRACTICE (in radiotherapy)radiotherapy)radiotherapy)radiotherapy)
Daniela Miladinova, MD PhD
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
Institute of Institute of Institute of Institute of PathophysiologyPathophysiologyPathophysiologyPathophysiologyandandandand Nuclear MedicineNuclear MedicineNuclear MedicineNuclear Medicine
• 2 experienced
physicists,
spec.
in medical
nuclear physics
6 grad.radiologic
technologies
Daniela Miladinova, MD PhD
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
University Clinic of Radiotherapy and University Clinic of Radiotherapy and University Clinic of Radiotherapy and University Clinic of Radiotherapy and OncologyOncologyOncologyOncology
• 4 specialists
• 1 on
specialization
• 5 physicists
Daniela Miladinova, MD PhD
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
M E D I C A L P H Y S I C S M E D I C A L P H Y S I C S
inininininininin private clinical practiceprivate clinical practice
Sonja Petkovska
ACIBADEM SISTINA Clinical Center
Shkoder 2014
What does it take to become a Medical Physicist?What does it take to become a Medical Physicist?
To be a medical physicist, you should:
have a high level of ability and interest in physical sciences and computing
have an interest in medicine and in the development of new methods of
patient care and treatment be accurate, able to concentrate for long
periods, and have a high level of attention to detail
What does it take to become a Medical Physicist?What does it take to become a Medical Physicist?
have high ethical standards and the ability to take responsibility for making
Decisions have an enquiring mind and good problem solving skills to lead
a research and development teamhave excellent oral and written
communication skills be able to reassure nervous patients.
Sonja Petkovska
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
25-Oct-14
What does a Medical Physicist doWhat does a Medical Physicist doWhat does a Medical Physicist doWhat does a Medical Physicist doWhat does a Medical Physicist doWhat does a Medical Physicist doWhat does a Medical Physicist doWhat does a Medical Physicist do??
• apply the principles of physics to patient care
• work closely with doctors and other professionals to assess and treat
ill health
• research, design and develop techniques and equipment used by
medical staff to diagnose and treat patients (alongside other specialist
physicists, clinical engineers and technical staff.
Shkoder 2014 Slide 50
What does it take to become a Medical Physicist?What does it take to become a Medical Physicist?
To be a medical physicist, you should:
have a high level of ability and interest in physical sciences and Computing
have an interest in medicine and in the development of new methods of
patient care and treatment be accurate, able to concentrate for long periods,
and have a high level of attention to detail.
have high ethical standards and the ability to take responsibility for making
decisionshave an enquiring mind and good problem solving skills to lead a
research and development team have excellent oral and written communi-
cation skills be able to reassure nervous patients
Sonja Petkovska
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08
FAREWELL
Shkodra 6/10/2014 - Y. LEMOIGNE / IFMP – Ambilly – France & CERN-Geneva-Switzerland35:08